These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11072484)

  • 21. Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study.
    Okugawa G; Kato M; Wakeno M; Koh J; Morikawa M; Matsumoto N; Shinosaki K; Yoneda H; Kishimoto T; Kinoshita T
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):322-8. PubMed ID: 19566763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder.
    Lasser RA; Bossie CA; Zhu Y; Gharabawi G; Eerdekens M; Davidson M
    Int J Geriatr Psychiatry; 2004 Sep; 19(9):898-905. PubMed ID: 15352149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The --1019 C/G polymorphism of the 5-HT(1)A receptor gene is associated with negative symptom response to risperidone treatment in schizophrenia patients.
    Wang L; Fang C; Zhang A; Du J; Yu L; Ma J; Feng G; Xing Q; He L
    J Psychopharmacol; 2008 Nov; 22(8):904-9. PubMed ID: 18308786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
    Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
    J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Composition and effects of commonly used neuroleptics.
    Culshaw F
    Nurs Times; 1994 Sep 21-27; 90(38):38-40. PubMed ID: 7971331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Schizophrenia and quality of life--new definition of therapeutic targets].
    Fortschr Neurol Psychiatr; 1997 Nov; 65(11 Suppl Schizophre):1-4. PubMed ID: 9431352
    [No Abstract]   [Full Text] [Related]  

  • 27. Combined use of atypical antipsychotics and cognitive-behavioural therapy in schizophrenia.
    Duggal HS
    Can J Psychiatry; 2002 Nov; 47(9):887-8. PubMed ID: 12500763
    [No Abstract]   [Full Text] [Related]  

  • 28. [Schizophrenia and quality of life--newly defined therapeutic targets].
    Psychiatr Prax; 1997 Nov; 24(6 Suppl Schizophre):1-4. PubMed ID: 9431365
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of schizophrenia. Long-term clinical studies with special reference to the combination of psychotherapy with depot neuroleptics.
    Lindberg D
    Acta Psychiatr Scand Suppl; 1981; 289():1-26. PubMed ID: 6110314
    [No Abstract]   [Full Text] [Related]  

  • 30. Chronic Cotard's syndrome: recovery from 2 years' bed-ridden status.
    Chou PH; Lin BT; Lan TH; Chan CH
    Psychiatry Clin Neurosci; 2011 Apr; 65(3):301. PubMed ID: 21507141
    [No Abstract]   [Full Text] [Related]  

  • 31. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms.
    McGorry PD; Yung AR; Phillips LJ; Yuen HP; Francey S; Cosgrave EM; Germano D; Bravin J; McDonald T; Blair A; Adlard S; Jackson H
    Arch Gen Psychiatry; 2002 Oct; 59(10):921-8. PubMed ID: 12365879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in the symptomatological picture of schizophrenia in relation to the introduction of neuroleptics].
    Modrzewska K
    Psychiatr Pol; 1988; 22(5):349-55. PubMed ID: 2907659
    [No Abstract]   [Full Text] [Related]  

  • 33. Talking back to madness.
    Balter M
    Science; 2014 Mar; 343(6176):1190-3. PubMed ID: 24626910
    [No Abstract]   [Full Text] [Related]  

  • 34. The maintenance of modified electroconvulsive therapy combined with risperidone is better than risperidone alone in preventing relapse of schizophrenia and improving cognitive function.
    Yang Y; Cheng X; Xu Q; Li R; Liu Z; Wang L; Zhang Y; Ren G; Liu J
    Arq Neuropsiquiatr; 2016 Oct; 74(10):823-828. PubMed ID: 27759808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of psychosocial therapy on the evolution of schizophrenia: comparative study].
    Montero I; Adam A; Gómez A; Leal I; Molero P; Santaolaya F
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(4):267-78. PubMed ID: 6151345
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of schizophrenia and spectrum disorders: pharmacotherapy, psychosocial treatments, and neurotransmitter interactions.
    Meltzer HY
    Biol Psychiatry; 1999 Nov; 46(10):1321-7. PubMed ID: 10578448
    [No Abstract]   [Full Text] [Related]  

  • 37. [Catamnestic study of schizophrenics treated with insulin coma therapy and schizophrenics treated with neuroleptics].
    Vachutka J
    Cesk Psychiatr; 1983 Dec; 79(6):392-5. PubMed ID: 6140083
    [No Abstract]   [Full Text] [Related]  

  • 38. [Arguments in favor of family psychotherapy combined with psychotropic therapy in schizophrenia].
    Diacicov S; Ionescu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1984; 29(2):131-40. PubMed ID: 6149607
    [No Abstract]   [Full Text] [Related]  

  • 39. [Anamnestic, clinical and psychodynamic data on a case of schizophrenia].
    Capobianco P; Bona Capobianco M
    Minerva Psichiatr; 1982; 23(1):47-54. PubMed ID: 6124861
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experience with preverbal psychotherapy in a group of chronic psychotic patients].
    Angosto Saura T; García Gómez M; Pérez Martín E; Alonso Seijo MM; Diz Quinteiro B; Formoso Caamaño ML; Molinos Louro MA; Vicente Vázquez M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(3):215-22. PubMed ID: 6485915
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.